CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Autres langues Charles River Laboratories International, Inc.

Actions

CRL

US1598641074

Recherche biotechnologique et médicale

Temps réel estimé Cboe BZX Autres places de cotation 17:33:29 07/08/2026			Varia. 5j.	Varia. 1 janv.
264,08 ^USD	-0,54 %		+13,87 %	+32,72 %

06/08	Charles River Laboratories International : une dirigeante cède pour 1 327 098 dollars d'actions, selon un document de la SEC	MT
06/08	CHARLES RIVER LABORATORIES INTERNATIONAL, INC. : Deutsche Bank Securities optimiste sur le dossier	ZM

Autres langues

06/08	Charles River Laboratories International Insider Sold Shares Worth $1,327,098, According to a Recent SEC Filing
06/08	Analyst recommendations: AppLovin, Emerson Electric, Roblox, Flutter Entertainment, HubSpot...
05/08	Top Midday Gainers
05/08	Tranche Update on Charles River Laboratories International, Inc.'s Equity Buyback Plan announced on November 5, 2025.
05/08	Charles River Laboratories International, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 27, 2026
05/08	Charles River Laboratories Fiscal Q2 Non-GAAP Earnings, Revenue Fall; Lifts 2026 Guidance
05/08	Charles River Laboratories International, Inc. Updates Earnings Guidance for 2026
05/08	(CRL) Charles River Laboratories Expects 2026 Adjusted EPS Range $11.15 - $11.45, vs. FactSet Est of $11.11
05/08	Earnings Flash (CRL) Charles River Laboratories Posts Fiscal Q2 Revenue $1.00B, vs. FactSet Est of $977.2M
05/08	Earnings Flash (CRL) Charles River Laboratories Posts Fiscal Q2 Adjusted EPS $3.02, vs. FactSet Est of $2.74
05/08	Charles River lifts profit forecast on improving biotech demand
05/08	Charles River: Q2 Earnings Snapshot
05/08	Charles River Laboratories Announces Second-Quarter 2026 Results
29/07	Align Technology to add directors, launch review after deal with Elliott
20/07	Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix…
15/07	Charles River Laboratories Schedules Second-Quarter 2026 Earnings Release and Conference Call
13/07	Charles River Laboratories to Provide Cell Sequencing Services to Arovella Therapeutics
13/07	Charles River Provides Ngs Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches
13/07	Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches
03/07	Did Charles River Laboratories International, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
01/07	Charles River Laboratories International Insider Sold Shares Worth $16,875,000, According to a Recent SEC Filing
18/06	Charles River Laboratories International, Inc. and Eli Lilly and Company Enter Collaboration to Optimize Ai/Ml Platform Through Nonclinical Testing Expertise
18/06	Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise
17/06	Charles River Laboratories Shares Rise After Morgan Stanley Upgrade
05/06	Charles River Laboratories Has Potential to Outperform in 2H 2026, RBC Says